US Stock MarketDetailed Quotes
KIDS OrthoPediatrics
- 23.380
- +0.805+3.57%
Close Dec 26 16:00 ET
- 23.380
- 0.0000.00%
Post 17:17 ET
566.17MMarket Cap-19.01P/E (TTM)
23.440High22.280Low207.71KVolume22.320Open22.575Pre Close4.83MTurnover1.27%Turnover RatioLossP/E (Static)24.22MShares35.99052wk High1.53P/B382.11MFloat Cap21.02052wk Low--Dividend TTM16.34MShs Float73.910Historical High--Div YieldTTM5.14%Amplitude14.000Historical Low23.249Avg Price1Lot Size
OrthoPediatrics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 36.53%54.57M | 33.48%52.8M | 41.46%44.69M | 21.62%148.73M | 21.36%37.61M | 14.37%39.97M | 20.14%39.56M | 34.89%31.59M | 24.72%122.29M | 24.91%30.99M |
| Operating revenue | 36.53%54.57M | 33.48%52.8M | 41.46%44.69M | 21.62%148.73M | 21.36%37.61M | 14.37%39.97M | 20.14%39.56M | 34.89%31.59M | 24.72%122.29M | 24.91%30.99M |
| Cost of revenue | 60.92%14.51M | 25.90%12M | 55.86%12.51M | 18.50%37.48M | 11.56%10.9M | -0.46%9.02M | 19.97%9.53M | 65.47%8.03M | 28.33%31.63M | 45.13%9.77M |
| Gross profit | 29.42%40.06M | 35.88%40.8M | 36.56%32.17M | 22.71%111.25M | 25.87%26.71M | 19.56%30.95M | 20.19%30.03M | 26.90%23.56M | 23.51%90.66M | 17.38%21.22M |
| Operating expense | 32.34%45.63M | 30.48%46.47M | 30.31%41.9M | 21.85%137.02M | 17.77%34.78M | 17.90%34.48M | 23.98%35.61M | 28.86%32.15M | 23.20%112.45M | 25.72%29.53M |
| Selling and administrative expenses | 34.89%43.05M | 34.54%43.92M | 30.95%38.9M | 21.44%126.82M | 18.39%32.56M | 18.05%31.92M | 21.01%32.65M | 29.58%29.71M | 21.81%104.44M | 25.66%27.5M |
| -Selling and marketing expense | 20.14%16.75M | 22.61%16.59M | 12.91%14.17M | 14.09%51.4M | 3.96%11.38M | 16.97%13.94M | 8.86%13.53M | 28.60%12.55M | 13.56%45.05M | 9.60%10.95M |
| -General and administrative expense | 46.33%26.3M | 42.99%27.33M | 44.14%24.73M | 27.01%75.42M | 27.94%21.18M | 18.90%17.97M | 31.39%19.11M | 30.30%17.16M | 28.92%59.38M | 39.13%16.55M |
| Research and development costs | 0.62%2.58M | -14.26%2.54M | 22.57%3M | 27.23%10.2M | 9.29%2.22M | 16.09%2.56M | 69.78%2.97M | 20.67%2.45M | 44.58%8.01M | 26.49%2.03M |
| Operating profit | -57.99%-5.57M | -1.43%-5.67M | -13.18%-9.72M | -18.25%-25.77M | 2.92%-8.07M | -5.10%-3.52M | -49.24%-5.59M | -34.53%-8.59M | -21.91%-21.79M | -53.56%-8.31M |
| Net non-operating interest income expense | -1,823.81%-404K | 11.22%-261K | -403.33%-637K | 108.17%198K | 396.72%303K | 97.03%-21K | 75.74%-294K | 137.10%210K | -7.88%-2.42M | 115.40%61K |
| Non-operating interest expense | 1,823.81%404K | -11.22%261K | ---- | ---- | ---- | -97.03%21K | -75.74%294K | ---- | ---- | ---- |
| Total other finance cost | ---- | ---- | 403.33%637K | -108.17%-198K | ---- | ---- | ---- | -137.10%-210K | 7.88%2.42M | ---- |
| Other net income (expense) | -1,499.49%-3.17M | -104.63%-120K | -97.60%24K | -79.26%4.26M | 144.32%860K | -101.07%-198K | -38.01%2.59M | 140.61%1M | 651.01%20.53M | -93.76%352K |
| Special income (charges) | -227.92%-3.23M | --0 | --0 | -91.06%2M | -98.75%6K | -105.08%-985K | -54.01%2.3M | 126.07%670K | 1,252.79%22.32M | -91.04%480K |
| -Less：Restructuring and merger&acquisition | --0 | --0 | --0 | 88.51%-2.98M | 98.75%-6K | --0 | 54.01%-2.3M | -126.07%-670K | -1,340.56%-25.93M | 91.29%-480K |
| -Less:Impairment of capital assets | --0 | ---- | ---- | -72.71%985K | --0 | -72.71%985K | ---- | ---- | --3.61M | --0 |
| -Less:Other special charges | --3.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -91.99%63K | -141.52%-120K | -92.75%24K | 225.89%2.26M | 767.19%854K | 183.28%787K | 134.95%289K | 215.24%331K | -265.84%-1.8M | -145.55%-128K |
| Income before tax | -144.17%-9.14M | -83.97%-6.05M | -40.05%-10.34M | -477.72%-21.31M | 12.58%-6.9M | -125.99%-3.74M | -325.78%-3.29M | 21.63%-7.38M | 78.78%-3.69M | -4,656.63%-7.9M |
| Income tax | -243.46%-1.22M | 95.51%-18K | -340.94%-2.53M | 93.17%-338K | -341.67%-212K | 120.49%849K | 8.66%-401K | -81.07%-574K | -338.56%-4.95M | 79.83%-48K |
| Net income | -72.49%-7.92M | -108.91%-6.03M | -14.68%-7.81M | -1,767.25%-20.97M | 14.74%-6.69M | -124.76%-4.59M | -766.67%-2.89M | 25.21%-6.81M | 107.74%1.26M | -11,000.00%-7.85M |
| Net income continuous Operations | -72.49%-7.92M | -108.91%-6.03M | -14.68%-7.81M | -1,767.25%-20.97M | 14.74%-6.69M | -124.76%-4.59M | -766.67%-2.89M | 25.21%-6.81M | 107.74%1.26M | -11,000.00%-7.85M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -72.49%-7.92M | -108.91%-6.03M | -14.68%-7.81M | -1,767.25%-20.97M | 14.74%-6.69M | -124.76%-4.59M | -766.67%-2.89M | 25.21%-6.81M | 107.74%1.26M | -11,000.00%-7.85M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 23K | -151K | |||||||
| Net income attributable to common stockholders | -72.49%-7.92M | -108.91%-6.03M | -14.68%-7.81M | -1,798.30%-20.97M | 13.07%-6.69M | -125.24%-4.59M | -766.67%-2.89M | 25.21%-6.81M | 107.60%1.24M | -10,790.28%-7.7M |
| Basic earnings per share | -70.00%-0.34 | -100.00%-0.26 | -13.33%-0.34 | -1,633.33%-0.92 | 17.14%-0.29 | -122.73%-0.2 | -550.00%-0.13 | 36.17%-0.3 | 107.14%0.06 | -9,483.38%-0.35 |
| Diluted earnings per share | -70.00%-0.34 | -100.00%-0.26 | -13.33%-0.34 | -1,633.33%-0.92 | 17.14%-0.29 | -122.99%-0.2 | -550.00%-0.13 | 36.17%-0.3 | 107.14%0.06 | -9,483.38%-0.35 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data